BioSpace News Archive

ArQule, Inc., (Nasdaq: ARQL) today announced that Paolo Pucci, CEO, Peter Lawrence, President and COO, Brian Schwartz, CMO and Head of R&D and Marc Schegerin, Senior Vice President and Head of Strategy, Finance and Communication, will participate in Citi’s 13th Annual Biotech Conference on September 6, 2018, at the Four Seasons Hotel in Boston, MA.

FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) reports today that its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”), has achieved positive results in a pre-clinical efficacy study of its proprietary “Steady Stomach” CBD combination product for Inflammatory Bowel Disease (IBD).

Veracyte, Inc. (Nasdaq: VCYT) announced that it has received a draft Medicare local coverage determination (LCD) for the Envisia Genomic Classifier through the MolDx program.

Demonstrating their growing role in moving Medicare payment from volume to value, ACOs in the MSSP generated $314 million in net savings to Medicare in 2017 after accounting for bonuses paid to ACOs, according to MSSP performance data released today by the Centers for Medicare & Medicaid Services (CMS).

This week the Trump administration was delivered another blow against its attempts to undo our apolitical civil service system and dismantle unions across the country.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of K2M Group Holdings, Inc. (“K2M”) (NasdaqGS: KTWO) to Stryker Corporation

Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced publication of the design and preclinical characterization of its lead product candidate, AG10, in the Journal of Medicinal Chemistry.

The U.S. District Court for the District of New Jersey entered an order of permanent injunction against S Hackett Marketing LLC doing business as Just Enhance; R Thomas Marketing LLC;

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for Alzheimer’s disease and diabetes, today announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference,

Capital Health Regional Medical Center (RMC), was recently recognized as the best hospital for Neurology and Neurosurgery in the Region in U.S. News & World Report Best Hospitals for 2018-19.